IBJNews

Lilly, GE announce cancer diagnostic breakthrough

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. and General Electric Co. say they’ve made a breakthrough in cancer research that could help Lilly cut the size and cost of its clinical trials.

The two companies, based in Indianapolis and New York, respectively, said they have developed a new protein mapping technique that allows scientists to observe 25 different biomarkers produced by cancer tumors at one time.

Currently, scientists can see only one or two biomarkers in a cancer tumor.

Biomarkers are proteins made by human cells. As their levels rise or fall in a person’s body, these proteins can indicate the presence of a disease. For example, high levels of hemoglobin A1C indicate diabetes.

Lilly measures how biomarkers respond to its drugs as a shortcut to determining if the drugs are working or not.

The technology, developed over the last two years with GE, will help Lilly predict in advance which patients are most likely to benefit from an experimental drug. By screening patients with the new tool, Lilly can test a drug on fewer patients, saving time and money.

Lilly will apply the technology it developed with GE to its clinical trials in summer 2010. Lilly has 20 different cancer drugs in clinical trials, roughly a third of its entire experimental pipeline.

Lilly has been working feverishly to speed up and reduce costs on its clinical trials. As of December, the company said its average cost to bring a drug to market had fallen from $1.2 billion in 2007 to $1 billion. The company wants to have an average cost of $800 million.

It needs such savings because Lilly is trying to move 61 different drugs through clinical trials, an enormously costly undertaking.

It needs to bring new drugs to market because several of its top-selling drugs will lose patent protection from 2010-2014, which will sap more than 50 percent of Lilly’s current sales.

To date, the new technology has been tested successfully on colon and prostate cancer tissue samples. GE and Lilly scientists think it can be applied to all types of cancer.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. How can any company that has the cash and other assets be allowed to simply foreclose and not pay the debt? Simon, pay the debt and sell the property yourself. Don't just stiff the bank with the loan and require them to find a buyer.

  2. If you only knew....

  3. The proposal is structured in such a way that a private company (who has competitors in the marketplace) has struck a deal to get "financing" through utility ratepayers via IPL. Competitors to BlueIndy are at disadvantage now. The story isn't "how green can we be" but how creative "financing" through captive ratepayers benefits a company whose proposal should sink or float in the competitive marketplace without customer funding. If it was a great idea there would be financing available. IBJ needs to be doing a story on the utility ratemaking piece of this (which is pretty complicated) but instead it suggests that folks are whining about paying for being green.

  4. The facts contained in your post make your position so much more credible than those based on sheer emotion. Thanks for enlightening us.

  5. Please consider a couple of economic realities: First, retail is more consolidated now than it was when malls like this were built. There used to be many department stores. Now, in essence, there is one--Macy's. Right off, you've eliminated the need for multiple anchor stores in malls. And in-line retailers have consolidated or folded or have stopped building new stores because so much of their business is now online. The Limited, for example, Next, malls are closing all over the country, even some of the former gems are now derelict.Times change. And finally, as the income level of any particular area declines, so do the retail offerings. Sad, but true.

ADVERTISEMENT